FundedIQ
Biotechnology

Sprout Pharmaceuticals: Funding, Investors & Team (Sep 2026)

Sprout Pharmaceuticals develops products for the treatment of female sexual dysfunction. They're committed to breakthrough firsts in women’s sexual health. The company was incorporated in 2011 and is based in Raleigh, North Carolina.

sproutpharmaceuticals.com LinkedIn Raleigh, United States 51-100 employees
Biotechnology Health Care Medical Pharmaceutical
Total raised
$25.1M
Rounds
1
Latest
Convertible Note
May 2022

Sprout Pharmaceuticals has raised $25.1M across 1 funding round on record, the most recent a Convertible Note of $25.1M announced in May 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Sprout Pharmaceuticals Company Profile and Key Stats

Total funding raised
$25.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Convertible Note
$25.1M in May 2022
Employees
51-100
reported band
Headquarters
Raleigh, United States

Latest funding round on record: May 2022.

Sprout Pharmaceuticals Funding Rounds

Date
Round
Amount
Convertible Note
$25.1M

Sprout Pharmaceuticals Founders and Leadership Team

Name
Role
Contact
Robert Whitehead
CEO

No contact details are on record for this team yet.

Sprout Pharmaceuticals Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Sprout Pharmaceuticals' latest round of $25.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Sprout Pharmaceuticals in Biotechnology and Raleigh

Companies Similar to Sprout Pharmaceuticals

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Sprout Pharmaceuticals Funding FAQs

What does Sprout Pharmaceuticals do?

Sprout Pharmaceuticals develops products for the treatment of female sexual dysfunction. They're committed to breakthrough firsts in women’s sexual health. The company was incorporated in 2011 and is based in Raleigh, North Carolina.

How much funding has Sprout Pharmaceuticals raised?

Sprout Pharmaceuticals has raised $25.1M across 1 round on record. The most recent is a Convertible Note of $25.1M announced in May 2022.

When did Sprout Pharmaceuticals last raise funding?

Sprout Pharmaceuticals' most recent funding round on record is a Convertible Note of $25.1M, announced in May 2022.

Who is the CEO of Sprout Pharmaceuticals?

Robert Whitehead is listed as CEO at Sprout Pharmaceuticals.

Where is Sprout Pharmaceuticals headquartered?

Sprout Pharmaceuticals is based in Raleigh, North Carolina, United States.

How many employees does Sprout Pharmaceuticals have?

Sprout Pharmaceuticals is in the 51-100 employee band.

How does Sprout Pharmaceuticals' funding compare to other Biotechnology startups?

Sprout Pharmaceuticals' latest round of $25.1M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Sprout Pharmaceuticals Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sprout Pharmaceuticals is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.